Clinical trialNCT07099898RecruitingPhase 3Interventional

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)

SponsorGlaxoSmithKlineEnrollment420Neoplasms, Lung

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

120 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Gsk Investigational Site
Mar del Plata, Buenos Aires, Argentina
Ignacio Casarini
Recruiting
Gsk Investigational Site
Buenos Aires, Argentina
Christian Fuentes
Recruiting
Gsk Investigational Site
Ciudad Autonoma de Buenos Aire, Argentina
Pedro Martin Paskevicius
Recruiting
Gsk Investigational Site
Ciudad Autonoma de Buenos Aire, Argentina
Nicolas Minatta
Recruiting
Gsk Investigational Site
Rosario, Argentina
Gabriel Garbaos
Recruiting
Gsk Investigational Site
Vicente López, Argentina
Gustavo Lopez
Recruiting

Australia

Gsk Investigational Site
Blacktown, New South Wales, Australia
Emma Boys
Recruiting
Gsk Investigational Site
St Leonards, New South Wales, Australia
Malinda Itchins
Recruiting
Gsk Investigational Site
Nedlands, Western Australia, Australia
Adnan Khattak
Recruiting

Brazil

Gsk Investigational Site
Barretos, Brazil
Flavio Augusto Ferreira da Silva
Recruiting
Gsk Investigational Site
CuritibaPR, Brazil
Karina Costa Maia Vianna
Recruiting
Gsk Investigational Site
Florianópolis, Brazil
Fabricio Grando
Recruiting
Gsk Investigational Site
Porto Alegre, Brazil
Katsuki Tiscoski
Recruiting
Gsk Investigational Site
Porto Alegre, Brazil
Ana Gelatti
Recruiting
Gsk Investigational Site
Rio de Janeiro, Brazil
Tatiane Montella
Recruiting
Gsk Investigational Site
São Paulo, Brazil
Gilberto De Castro Junior
Recruiting

Bulgaria

Gsk Investigational Site
Pleven, Bulgaria
Yordan Ignatov
Recruiting
Gsk Investigational Site
Plovdiv, Bulgaria
Vladimir Kanarev
Recruiting
Gsk Investigational Site
Rousse, Bulgaria
Nikolay Nikolaev
Recruiting
Gsk Investigational Site
Sofia, Bulgaria
Zhasmina Mihaylova
Recruiting

Canada

Gsk Investigational Site
Ottawa, Ontario, Canada
Paul Wheatley-Price
Recruiting
Gsk Investigational Site
Toronto, Ontario, Canada
Natasha Leighl
Recruiting
Gsk Investigational Site
Montreal, Quebec, Canada
Jennifer Friedmann
Recruiting
Gsk Investigational Site
Montreal, Quebec, Canada
Kevin Jao
Recruiting

Finland

Gsk Investigational Site
Vaasa, Finland
Ravichandra Ravi
Recruiting

France

Gsk Investigational Site
Boulogne-Billancourt, France
Etienne Giroux Leprieur
Recruiting
Gsk Investigational Site
Grenoble, France
Denis Moro-Sibilot
Recruiting
Gsk Investigational Site
Saint-Herblain, France
Sandrine Hiret
Recruiting

Germany

Gsk Investigational Site
Karlsruhe, Baden-Wurttemberg, Germany
Christian Meyer zum Bueschenfelde
Recruiting
Gsk Investigational Site
Augsburg, Germany
Bjoern Hackanson
Recruiting
Gsk Investigational Site
Chemnitz, Germany
Stefan Hammerschmidt
Recruiting
Gsk Investigational Site
Esslingen am Neckar, Germany
Martin Faehling
Recruiting
Gsk Investigational Site
Lübeck, Germany
Jens Kisro
Recruiting
Gsk Investigational Site
München, Germany
Diego Kauffmann-Guerrero
Recruiting
Gsk Investigational Site
Nuremberg, Germany
Markus Horneber
Recruiting
Gsk Investigational Site
Stuttgart, Germany
Perihan Canoglu
Recruiting

Greece

Gsk Investigational Site
Athens, Greece
Ioannis Mountzios
Recruiting
Gsk Investigational Site
Athens, Greece
Amanda Psyrri
Recruiting
Gsk Investigational Site
Athens, Greece
ANASTASIOS GRIVAS
Recruiting
Gsk Investigational Site
Heraklion Crete, Greece
Sofia Agelaki
Recruiting

80 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 11 Aug 2025
Primary completion: 5 Nov 2027
Completion: 28 Sept 2029
Last update posted: 27 May 2026
Registered enrollment: 420
Registry id: NCT07099898

Cross-registrations

EU-CTR / CTIS (EudraCT)2025-521627-78-00

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.